Source: Annual Congress 2005 - COPD - outcome
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Sergey, M. Zamira, K. Sergey, G. Nuralieva, C. Alexander (Moscow, Russian Federation). Community-acquired pneumonia as a cause of acute respiratory failure (ARF) in COPD patients. Eur Respir J 2005; 26: Suppl. 49, 3373

Member's Comments

No comment yet.

Related content which might interest you: Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 42s Year: 2007 Non-invasive ventilation (NIV) in community-acquired pneumonia CAP) and severe acute respiratory failure (ARF): Effectiveness and risk factors for failure and mortality Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure Year: 2011 Acute respiratory failure and severe sepsis may identify different clinical phenotypes in community-acquired pneumonia Source: Annual Congress 2013 –Interesting research questions Year: 2013 COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006 Cryptogenic organizing pneumonia (COP) as a cause of severe acute respiratory failure Source: Eur Respir J 2004; 24: Suppl. 48, 507s Year: 2004 Type of acute respiratory failure and development of ventilator-associated pneumonia (VAP) Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Community-acquired pneumonia (CAP) in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Characteristics of pnemococcal community-acquired pneumonia presenting with respiratory failure Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients? Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients Year: 2015 Community-acquired pneumonia (CAP) in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 338s Year: 2003 Community-acquired pneumonia (CAP) and mortality risk in patients with congestive heart failure (CHF) Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002 Community-acquired pneumonia (CAP): differences between patients with chronic obstructive pulmonary disease (COPD) and those without COPD Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients Source: Eur Respir J 2012; 39: 855-861 Year: 2012 NIV: indication in case of acute hypoxaemic respiratory failure (pulmonary oedema and immunosuppressed patients excluded) Source: Eur Respir Mon; 2008: 41: 60–71 Year: 2008 Detection of liver function in patients with severe community-acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 15s Year: 2002 Diagnosis on community-acquired pneumonia (CAP) in patients with congestive heart failure (CHF) Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Heliox-therapy of patients with execerbation of COPD and community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 106s Year: 2006 Home-NIV in patients with COPD after acute respiratory failure Source: Annual Congress 2008 - Noninvasive mechanical ventilation in the acute setting Year: 2008